RetiPharma logo

RetiPharma IVS

RetiPharma is developing products for treatment of degenerative eye disorders in parallel with building a unique translational in vivo platform. The company is founded on neuroprotective research conducted by scientist at the University of Copenhagen and the University Hospital, Rigshospitalet.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://retipharma.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Ole Maaløes Vej 3, Capital Region 2200
København N
Denmark
Email
Contact Number
+45 30 30 40 83

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/retipharma” connections=”true” suffix=””]